Literature DB >> 25211057

Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma.

Jun Zhao1, Jody Vykoukal, Mohamed Abdelsalam, Alejandro Recio-Boiles, Qian Huang, Yang Qiao, Burapol Singhana, Michael Wallace, Rony Avritscher, Marites P Melancon.   

Abstract

The treatment of liver injuries or hepatocellular carcinoma (HCC) has been hindered by the lack of efficient drug delivery. Even with the help of nanoparticles or other synthetic delivering agents, a large portion of the dose is still sequestered in the reticuloendothelial system. As an alternative, adipose-derived mesenchymal cells (AD-MSCs), which have the capability of homing to the injured liver, can be used as a unique carrier for theranostic agents. Theranostic agents must have the capacity for being non-toxic to host cells during transportation, and for timely activation once they arrive at the injury sites. In this study, we loaded AD-MSCs with superparamagnetic iron oxide-coated gold nanoparticles (SPIO@AuNPs) and tested their effects against liver injury and HCC in cells and in mice. SPIO@AuNP is a non-toxic magnetic resonance (MR)-active contrast agent that can generate heat when irradiated with near-infrared laser. Our results showed that SPIO@AuNPs were successfully transfected into AD-MSCs without compromising either cell viability (P > 0.05) or cell differentiability. In vivo MR imaging and histologic analysis confirmed the active homing of AD-MSCs. Upon laser irradiation, the SPIO@AuNP-loaded AD-MSCs could thermally ablate surrounding HCC tumor cells. SPIO@AuNP-loaded AD-MSCs proved a promising theranostic approach for injured liver and HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211057      PMCID: PMC4414337          DOI: 10.1088/0957-4484/25/40/405101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  20 in total

1.  T lymphocytes as potential therapeutic drug carrier for cancer treatment.

Authors:  Ute Steinfeld; Christine Pauli; Nikolas Kaltz; Christian Bergemann; Hyeck-Hee Lee
Journal:  Int J Pharm       Date:  2006-02-07       Impact factor: 5.875

2.  Targeted multifunctional gold-based nanoshells for magnetic resonance-guided laser ablation of head and neck cancer.

Authors:  Marites P Melancon; Wei Lu; Meng Zhong; Min Zhou; Gan Liang; Andrew M Elliott; John D Hazle; Jeffrey N Myers; Chun Li; R Jason Stafford
Journal:  Biomaterials       Date:  2011-07-13       Impact factor: 12.479

Review 3.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

4.  Implanted adipose-derived stem cells attenuate small-for-size liver graft injury by secretion of VEGF in rats.

Authors:  T Ma; H Liu; W Chen; X Xia; X Bai; L Liang; Y Zhang; T Liang
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

5.  Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy.

Authors:  Linlin Li; Yunqian Guan; Huiyu Liu; Nanjing Hao; Tianlong Liu; Xianwei Meng; Changhui Fu; Yanzhen Li; Qiulian Qu; Yingge Zhang; Shangyi Ji; Ling Chen; Dong Chen; Fangqiong Tang
Journal:  ACS Nano       Date:  2011-08-24       Impact factor: 15.881

Review 6.  Primary liver tumors: origin and target therapy.

Authors:  Michail Papoulas; Stamatios Theocharis
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

7.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

Authors:  Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

8.  PiggyBac transposon-mediated, reversible gene transfer in human embryonic stem cells.

Authors:  You-Tzung Chen; Kenryo Furushima; Pei-Shan Hou; Amy T Ku; Jian Min Deng; Chuan-Wei Jang; Haotian Fang; Henry P Adams; Min-Liang Kuo; Hong-Nerng Ho; Chung-Liang Chien; Richard R Behringer
Journal:  Stem Cells Dev       Date:  2010-06       Impact factor: 3.272

9.  Differential cell sensitivity between OTA and LPS upon releasing TNF-α.

Authors:  Lauy Al-Anati; Ebtisam Essid; Ulla Stenius; Knut Beuerlein; Klaus Schuh; Ernst Petzinger
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

10.  Development of a vascularized skin construct using adipose-derived stem cells from debrided burned skin.

Authors:  Rodney K Chan; David O Zamora; Nicole L Wrice; David G Baer; Evan M Renz; Robert J Christy; Shanmugasundaram Natesan
Journal:  Stem Cells Int       Date:  2012-07-05       Impact factor: 5.443

View more
  16 in total

1.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 2.  Stromal cells and stem cells in clinical bone regeneration.

Authors:  Warren L Grayson; Bruce A Bunnell; Elizabeth Martin; Trivia Frazier; Ben P Hung; Jeffrey M Gimble
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

3.  Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection.

Authors:  Yang Qiao; Joy Gumin; Christopher J MacLellan; Feng Gao; Richard Bouchard; Frederick F Lang; R Jason Stafford; Marites P Melancon
Journal:  Nanotechnology       Date:  2018-04-20       Impact factor: 3.874

Review 4.  Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

Authors:  Hoda Elkhenany; Ahmed Shekshek; Mohamed Abdel-Daim; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Design strategies and applications of circulating cell-mediated drug delivery systems.

Authors:  Yixue Su; Zhiwei Xie; Gloria B Kim; Cheng Dong; Jian Yang
Journal:  ACS Biomater Sci Eng       Date:  2015-03-12

Review 6.  Development of individualized anti-metastasis strategies by engineering nanomedicines.

Authors:  Qianjun He; Shengrong Guo; Zhiyong Qian; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2015-06-09       Impact factor: 54.564

Review 7.  Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Winston W-Y Kao
Journal:  Ocul Surf       Date:  2016-01-12       Impact factor: 5.033

8.  Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment.

Authors:  Megan E Muroski; Ramin A Morshed; Yu Cheng; Tarun Vemulkar; Rhodri Mansell; Yu Han; Lingjiao Zhang; Karen S Aboody; Russell P Cowburn; Maciej S Lesniak
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

Review 9.  Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy.

Authors:  Li Tian; Linfeng Lu; Yang Qiao; Saisree Ravi; Ferandre Salatan; Marites P Melancon
Journal:  J Funct Biomater       Date:  2016-07-21

Review 10.  Noninvasive in-vivo tracing and imaging of transplanted stem cells for liver regeneration.

Authors:  Panpan Cen; Jiajia Chen; Chenxia Hu; Linxiao Fan; Jie Wang; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2016-09-23       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.